Uli Broedl MD

Dr. Uli Broedl, MD, is Medical Director and Vice President of Medical and Regulatory Affairs at Boehringer Ingelheim Canada since January 2017. He is the medical representative of the company’s executive leadership team and oversees all aspects of clinical operations, clinical development, medical affairs, regulatory affairs, drug safety, and clinical quality management. Dr. Broedl is passionate about fostering innovation. Dr. Broedl is an adjunct Professor of Medicine at the University of Munich, Germany, and holds a Doctorate of Medicine degree from the University of Munich. He completed a Postdoctoral Fellowship in Dr. Daniel J. Rader ́s lab, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, and completed his training in Internal Medicine, Endocrinology, and Metabolism at the Medical Center of the University of Munich.